Moxifloxacin HCL prices recorded an upsurged price trajectory in the international market on the back of a tightened supply. The manufacturing processes and the strong demand from the global market both contribute to the price increase for Moxifloxacin HCl. The exporting tendency from India, a significant exporter of this API to various other regions, including Germany, the USA, etc., was insufficient to meet the surging demand, which prompted the price value of Moxifloxacin HCl.

Moxifloxacin HCl prices in China were recorded with a monthly inclination of 10.30% due to limited stock levels and increased demand from the pharmaceutical industries. On the other hand, the weak production in the Chinese domestic market ushered in disrupted trade with the zero-Covid policy and strict policies imposed in China, further pushing the price value of Moxifloxacin HCl.

Similarly, the USA Moxifloxacin HCl market also witnessed a similar market dynamic and struggled with consistent downstream demand and interrupted supplies. Disrupted supply chain amidst port congestion and worsening logistics and import activities in the US market. Hence, as of result, Moxifloxacin HCl demonstrates an inclination of 5.49% with its higher downstream demand. Moreover, the import frequency from other regions has also been affected by the slowdown in China's economic activity caused by port congestion and temporary closures in several states.

Additionally, European countries followed a similar trend as even in Germany, the price trend for Moxifloxacin HCl shot up by 6.10 percent in August. Insufficient product availability from China led German traders to import Moxifloxacin HCl at a high cost from India, prompting a price hike. Since China is one of the primary exporters of all the Pharmaceutical API, a turnaround in some manufacturing activities and affected climatic condition affects the overall importing momentum worldwide.

According to Chemanalyst, "Uninterrupted supply and difficulty in the availability are likely to increase the prices for Moxifloxacin HCl in forthcoming months.